X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (355) 355
Publication (34) 34
Book Chapter (7) 7
Book / eBook (5) 5
Newsletter (5) 5
Book Review (3) 3
Conference Proceeding (1) 1
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (272) 272
index medicus (223) 223
female (174) 174
male (156) 156
middle aged (141) 141
adult (125) 125
oncology (122) 122
aged (114) 114
hematology (100) 100
transplantation (97) 97
activities of daily living (88) 88
cyclophosphamide (82) 82
daily oral cyclophosphamide (81) 81
immunology (80) 80
daily intravenous busulfan (78) 78
chemotherapy (75) 75
bone-marrow-transplantation (72) 72
treatment outcome (72) 72
cancer (68) 68
busulfan (67) 67
care and treatment (63) 63
busulfan - administration & dosage (62) 62
hematopoietic stem cells (62) 62
adolescent (56) 56
randomized-trial (56) 56
pharmacokinetics (53) 53
analysis (51) 51
anca-associated vasculitis (51) 51
transplantation conditioning - methods (49) 49
medicine & public health (48) 48
stem-cell transplantation (48) 48
health aspects (47) 47
stem cells (47) 47
antibody-associated vasculitis (46) 46
retrospective studies (46) 46
rheumatology (46) 46
fludarabine (43) 43
hematopoietic stem cell transplantation - methods (43) 43
busulfan - pharmacokinetics (40) 40
hematopoietic stem cell transplantation (40) 40
research (40) 40
pharmacology & pharmacy (39) 39
quality of life (39) 39
term-follow-up (39) 39
vidarabine - analogs & derivatives (39) 39
hematology, oncology and palliative medicine (38) 38
vasculitis (38) 38
versus-host-disease (38) 38
young adult (38) 38
rituximab (36) 36
children (35) 35
dosage and administration (35) 35
immunosuppressive agents - therapeutic use (35) 35
recurrence (35) 35
antineoplastic combined chemotherapy protocols - therapeutic use (34) 34
child (34) 34
risk factors (34) 34
therapy (34) 34
drug administration schedule (33) 33
cyclophosphamide - administration & dosage (32) 32
daily filgrastim (31) 31
total-body irradiation (31) 31
wegeners-granulomatosis (31) 31
breast cancer (29) 29
double-blind (29) 29
drug therapy (29) 29
microscopic polyangiitis (29) 29
mortality (29) 29
patients (29) 29
prognosis (29) 29
transplantation, homologous (29) 29
cyclophosphamide - therapeutic use (28) 28
immunosuppressive agents - administration & dosage (28) 28
urology & nephrology (27) 27
vidarabine - administration & dosage (27) 27
conditioning regimen (26) 26
remission induction (26) 26
survival rate (26) 26
acute myeloid-leukemia (25) 25
aged, 80 and over (25) 25
anti-neutrophil cytoplasmic antibody-associated vasculitis - drug therapy (25) 25
breast neoplasms - drug therapy (25) 25
disease-free survival (25) 25
follow-up studies (25) 25
article (24) 24
child, preschool (24) 24
prospective studies (24) 24
neutropenia (23) 23
antineoplastic combined chemotherapy protocols - adverse effects (22) 22
single-administration pegfilgrastim (22) 22
survival analysis (22) 22
toxicity (22) 22
antineoplastic agents (21) 21
health care sciences & services (21) 21
leukemia (21) 21
oral busulfan (21) 21
remission (21) 21
antineoplastic combined chemotherapy protocols - administration & dosage (20) 20
daily iv busulfan (20) 20
granulomatosis with polyangiitis (20) 20
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (5) 5
Humber River Regional Hospital - Church Stacks (1) 1
Providence Healthcare - Stacks (1) 1
Scarborough Hospital - General (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
Toronto East General Hospital - Stacks (1) 1
UTL at Downsview - May be requested (1) 1
Victoria University E.J. Pratt - Stacks (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 09/2016, Volume 75, Issue 9, pp. 1583 - 1594
Journal Article
Autoimmunity Reviews, ISSN 1568-9972, 10/2018, Volume 17, Issue 10, pp. 1022 - 1027
Cyclophosphamide is a prodrug that is converted to inactive carboxy-cyclophosphamide, acrolein and phosphoramide mustard, an agent that adds alkyl groups to... 
Drug metabolism | Cyclophosphamide | Glomerular disease | DAILY ORAL CYCLOPHOSPHAMIDE | VASCULITIS | INDUCTION | IMMUNOLOGY | THERAPY | LUPUS NEPHRITIS | RITUXIMAB | PULSE | IGA NEPHROPATHY | IDIOPATHIC NEPHROTIC SYNDROME | LONG | Lupus | Kidney diseases | Nitrogen | Leukemia | Index Medicus
Journal Article
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, ISSN 0889-857X, 08/2019, Volume 45, Issue 3, pp. 379 - 379
Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a group of systemic necrotizing vasculitides that includes granulomatosis with... 
WEGENERS-GRANULOMATOSIS | NERVOUS-SYSTEM INVOLVEMENT | DAILY ORAL CYCLOPHOSPHAMIDE | Rituximab | RANDOMIZED-TRIAL | POOR-PROGNOSIS FACTORS | RHEUMATOLOGY | ANCA-associated vasculitis | Cyclophosphamide | Treatment | POLYANGIITIS CHURG-STRAUSS | EOSINOPHILIC GRANULOMATOSIS | REMISSION MAINTENANCE | MYCOPHENOLATE-MOFETIL | Remission induction
Journal Article
Clinical Journal of the American Society of Nephrology, ISSN 1555-9041, 2014, Volume 9, Issue 9, pp. 1571 - 1576
Journal Article